Liver-directed chemotherapy of cetuximab and bevacizumab in combination with oxaliplatin is more effective to inhibit tumor growth of CC531 colorectal rat liver metastases than systemic chemotherapy

Colorectal carcinoma is, through to its high rate of liver metastasis (mCRC), the second most cause of cancer death worldwide. Tumor resection represents the only potential cure. In cases of unresectable disease systemic chemotherapy (sCHT) remains the therapy of choice. Modern sCHT regimens includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sperling, Jens, Brandhorst, David, Schäfer, Thilo, Ziemann, Christian, Benz-Weißer, Anna, Scheuer, Claudia, Kollmar, Otto, Schilling, Martin K., Menger, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616223/
https://www.ncbi.nlm.nih.gov/pubmed/23187934
http://dx.doi.org/10.1007/s10585-012-9550-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616223/
https://www.ncbi.nlm.nih.gov/pubmed/23187934
http://dx.doi.org/10.1007/s10585-012-9550-9

Ejemplares similares